EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Rumeysa Ciftci, Faruk Tas, Elif Bilgin, Serkan Keskin, Ibrahim Yildiz, Derya Duranyildiz, Pınar Saip, Hasan Karanlik, Sezai Vatansever

Journal of Oncological Science · 2016

DOI: 10.1016/j.jons.2016.04.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncological Science, 2016. Verfasst von Rumeysa Ciftci und 8 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ciftci, R., Tas, F., Bilgin, E., Keskin, S., Yildiz, I., Duranyildiz, D., Saip, P., Karanlik, H., & Vatansever, S. (2016). Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer. Journal of Oncological Science. https://doi.org/10.1016/j.jons.2016.04.003

Vancouver

Ciftci R, Tas F, Bilgin E, Keskin S, Yildiz I, Duranyildiz D, et al. Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer. Journal of Oncological Science. 2016. doi:10.1016/j.jons.2016.04.003

BibTeX
@article{Ciftci2016,
  author = {Ciftci, Rumeysa and Tas, Faruk and Bilgin, Elif and Keskin, Serkan and Yildiz, Ibrahim and Duranyildiz, Derya and Saip, Pınar and Karanlik, Hasan and Vatansever, Sezai},
  title = {Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer},
  journal = {Journal of Oncological Science},
  year = {2016},
  doi = {10.1016/j.jons.2016.04.003}
}
Kostenlos starten →